Sector
Healthcare
Industry
Medical - Equipment & Services
Employees
246
First IPO Date
June 10, 2015
| Name | Title | Pay | Year Born |
| Jouni Toijala | President & Chief Executive Officer | 438,944 | 1968 |
| Juha Jaatinen | Interim Chief Financial Officer | 0 | 1965 |
| John Floyd | Vice President of Sales | 0 | 1970 |
| Robin Pulkkinen | Chief Financial Officer | 0 | 1980 |
| Hanna Vuornos | Vice President of People & Culture | 0 | 1978 |
| Ari Isomäki | Vice President of Operations | 0 | 1966 |
| Erkki Tala | Vice President of Products, Brand & Marketing | 0 | 1977 |
Revenio Group Oyj operates as a healthcare technology company, specializing in the development, production, and global distribution of advanced ophthalmic diagnostic instruments and medical devices. These innovations are engineered to aid in the identification of various eye conditions, including glaucoma, macular degeneration, diabetic retinopathy, and cataracts, serving clientele in Finland, throughout Europe, and worldwide. Its extensive product portfolio includes the iCare IC100 and IC200 tonometers, along with the iCare HOME device for personal eye pressure monitoring. Furthermore, the company provides sophisticated imaging technologies such as the iCare EIDON AF for confocal retinal imaging, DRSplus for screening diabetic retinopathy, the iCare MAIA microperimeter for precise visual field measurements, and iCare COMPASS, which facilitates fundus perimetry using true-color retinal images. Beyond hardware, Revenio also offers Oculo, a comprehensive eye care software platform that seamlessly integrates clinical communication, telehealth functionalities, remote patient monitoring, and robust data analytics. Established in 2001, Revenio Group Oyj is based in Vantaa, Finland.